Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 574

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

Open access
Higashi, Kyoko, Medic, Goran, Littlewood, Kavi J., Diez, Teresa, Granström, Ola, De Hert, Marc·2013·Therapeutic Advances in Psychopharmacology

Abstract

Background: Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment. Methods: We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization. Results: Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse, hospitalization and suicide. Factors positively related to adherence were a good therapeutic relationship with physician and perception of benefits of medication. The most frequently reported driver and consequence were lack of insight and greater risk of hospitalization respectively. Conclusions: Improving adherence in schizophrenia may have a considerable positive impact on patients and society. This can be achieved by focusing on the identified multitude of factors driving nonadherence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2045125312474019

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 7

  1. American Psychiatric Association, 2006, Evidence-Based Treatments for Schizophrenia: Information for families and Other Supporters
  2. Kozma C., 2009, Am Health Drug Benefits, 2, 31
  3. 10.1055/s-0030-1254090 · doi:10.1055/s-0030-1254090
  4. 10.1016/S0278-5846(01)00294-9 · doi:10.1016/s0278-5846(01)00294-9
  5. Svestka J., 2007, Neuroendocrinol Lett, 28, 95
  6. 10.4088/JCP.v65n0812 · doi:10.4088/jcp.v65n0812
  7. World Health Organization, 2011, Schizophrenia

Cited by

See all 574

Metadata

Authors
Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granström, O., & De Hert, M.
Venue
Therapeutic Advances in Psychopharmacology
Published
2013-02-04
Volume
3
Issue
4
Pages
200-218
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W2057464084
Cited by
574
References
45
FWCI
3.00
Type
journal article
Language
en
Open access
bronze
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. https://app.cochat.ai/papers/10.1177/2045125312474019
The paper
Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granström, O., & De Hert, M. (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125312474019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.